Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Functions of glutaminyl cyclase and its isoform in diseases
Yue Liu, Yufeng Shi, Ping Wang
Visualized Cancer Medicine (2023) Vol. 4, pp. 1-1
Open Access | Times Cited: 11

Showing 11 citing articles:

Emerging phagocytosis checkpoints in cancer immunotherapy
Yue Liu, Yanjin Wang, Yanrong Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 152
Targeting QPCTL: An Emerging Therapeutic Opportunity
Lei Yu, Yaoliang Sun, Long-Yan Xie, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 2
Deciphering the role of CD47 in cancer immunotherapy
Yue Liu, Linjun Weng, Yanjin Wang, et al.
Journal of Advanced Research (2023) Vol. 63, pp. 129-158
Open Access | Times Cited: 26
Navigating the dementia landscape: Biomarkers and emerging therapies
Shubhrat Maheshwari, Aditya Singh, Valeed Ahmad Ansari, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102193-102193
Closed Access | Times Cited: 14
Targeting macrophages in cancer immunotherapy: Frontiers and challenges
Yue Liu, Huabing Tan, Jingyuan Dai, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 1
Deciphering the role of QPCTL in glioma progression and cancer immunotherapy
Yue Liu, Shaojuan Lu, Yihong Sun, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Caveolin-1 promotes glioma progression and maintains its mitochondrial inhibition resistance
Yue Liu, Yi Chen, Fei Wang, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Five Key Criteria for Identifying Optimal Therapeutic Targets in Protein‐Mediated Diseases
Mohammed Baqur S. Al‐Shuhaib, Jafar M. B. Al‐Shuhaib
ChemistrySelect (2025) Vol. 10, Iss. 4
Closed Access
Identification of imidazole-based small molecules to combat cognitive disability caused by Alzheimer’s disease: A molecular docking and MD simulations based approach
Ashanul Haque, Khalaf M. Alenezi, Mohd. Saeed Maulana Abdul Rasheed
Computational Biology and Chemistry (2024) Vol. 112, pp. 108152-108152
Closed Access | Times Cited: 2
Role of glutaminyl-peptide cyclo-transferase-like protein (QPCTL) in cancer: From molecular mechanisms to immunotherapy
Enwa Felix Oghenemaro, Subasini Uthirapathy, Deepak Nathiya, et al.
Gene (2024), pp. 149153-149153
Closed Access | Times Cited: 2
Diversity of amyloid beta peptide actions
Sona Mardanyan, Svetlana Sharoyan, Alvard Antonyan
Reviews in the Neurosciences (2024) Vol. 35, Iss. 4, pp. 387-398
Closed Access | Times Cited: 1
Page 1

Scroll to top